SCHEMBL996104

SCHEMBL996104

O=S(=O)(Cl)c1cccc(-c2ncccn2)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
KAT6A Q92794 6/20 0.48
CLK4 Q9HAZ1 2/20 0.44
DYRK1A Q13627 1/20 0.44
CYP3A4 P08684 1/20 0.42
CA9 Q16790 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CYP2A6 P11509 1/20 0.38
CYP19A1 P11511 1/20 0.36
ADRB2 P07550 1/20 0.36
TRPV4 Q9HBA0 1/20 0.36
NFE2L2 Q16236 1/20 0.36
IKBKB O14920 1/20 0.35
CHUK O15111 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10408548 0.82 ALDH1A1 (0.56) ALDH1A1HSD17B10TDP1CA9CA12
SCHEMBL27807845 0.81 LOXL2 (0.49) KAT6ACLK4DYRK1A
SCHEMBL998552 0.80 CYP3A4 (0.50) ALDH1A1HSD17B10TDP1KAT6ACLK4
SCHEMBL297270 0.76 ALDH1A1 (0.62) ALDH1A1HSD17B10TDP1KAT6ACA9
SCHEMBL18118205 0.75 HPGDS (0.44) ALDH1A1HSD17B10TDP1CA9CA12
SCHEMBL1074656 0.75 KAT6A (0.52) ALDH1A1HSD17B10TDP1KAT6ACYP2A6
SCHEMBL14961829 0.75 CLK4 (0.61) KAT6ACLK4DYRK1ACYP2A6CYP19A1
SCHEMBL56599 0.75 ALDH1A1 (0.65) ALDH1A1HSD17B10TDP1CA9CA12
SCHEMBL6545877 0.75 ALDH1A1 (0.54) ALDH1A1HSD17B10TDP1KAT6ACA9
SCHEMBL10248780 0.73 ACLY (0.53) ALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718264-B1 BENZOCYCLOHEPTENE ACETIC ACIDS HOFFMANN LA ROCHE (CH) 2015-08-05 EP disclosed
EP-2456435-B1 HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE UNIV LELAND STANFORD JUNIOR (US) 2015-06-24 EP disclosed
EP-2718264-A1 BENZOCYCLOHEPTENE ACETIC ACIDS F.HOFFMANN-LA ROCHE AG (CH) 2014-04-16 EP disclosed
WO-2012168162-A1 BENZOCYCLOHEPTENE ACETIC ACIDS F. HOFFMANN-LA ROCHE AG (CH) 2012-12-13 WO disclosed
US-20120309796-A1 BENZOCYCLOHEPTENE ACETIC ACIDS FIROOZNIA FARIBORZ (US) 2012-12-06 US disclosed
US-20120225862-A1 HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE AUCKLAND UNIVSERVICES LIMITED (NZ) 2012-09-06 US disclosed
EP-2456435-A1 HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE The Board of Trustees of The Leland Stanford Junior University (US) 2012-05-30 EP disclosed
WO-2011011514-A1 HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120225862-A1 HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE BRDT, NISCH, PAICS ALDH1A1 1336/4885HSD17B10 554/4885TDP1 2013/4885
US-20120309796-A1 BENZOCYCLOHEPTENE ACETIC ACIDS ACAT2, ACAT1, CYP27A1 ALDH1A1 26/4885HSD17B10 24/4885TDP1 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.